MedPath

ENALAPRILAT INJECTION USP

ENALAPRILAT INJECTION USP

Approved
DIN Number

02388499

Drug Class

Human

Market Date

Sep 10, 2012

Company
HC

hikma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02388499
AIG Number0118001001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09AA02 ENALAPRIL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:32.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

ENALAPRILATActive
Strength: 1.25 MG / ML
Monograph: ENALAPRILAT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.